Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parathyroid Gland Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Study completedNCT03280264
What this trial is testing

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

Who this might be right for
Parathyroid CarcinomaPrimary Hyperparathyroidism
Kyowa Kirin Co., Ltd. 18
Not applicableLooking for participantsNCT06645951
What this trial is testing

Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma

Who this might be right for
Parathyroid Gland CarcinomaParathyroid Gland Atypical Adenoma
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore 300
Testing effectiveness (Phase 2)Study completedNCT01087970
What this trial is testing

Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Eli Lilly and Company 69
Not applicableUnknownNCT04424485
What this trial is testing

Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy

Who this might be right for
Thyroid CancerThyroid Carcinoma, PapillaryThyroid Metastases+3 more
Umraniye Education and Research Hospital 100
Early research (Phase 1)Study completedNCT00580320
What this trial is testing

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Who this might be right for
MelanomaSoft Tissue SarcomaParathyroid Carcinoma+2 more
Virginia Commonwealth University 17
Not applicableStudy completedNCT03046524
What this trial is testing

Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior

Who this might be right for
Parathyroid CarcinomaParathyroid Neoplasm
M.D. Anderson Cancer Center 100
Not applicableLooking for participantsNCT03039439
What this trial is testing

Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

Who this might be right for
Parathyroid Gland AdenomaParathyroid Gland Atypical AdenomaParathyroid Gland Carcinoma+1 more
M.D. Anderson Cancer Center 310
Early research (Phase 1)Study completedNCT00673010
What this trial is testing

Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 20
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Looking for participantsNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Not applicableUnknownNCT05789680
What this trial is testing

European Multicentric Study on Parathyroid Carcinoma

Who this might be right for
Parathyroid Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 17
Not applicableStudy completedNCT00068497
What this trial is testing

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableStudy completedNCT02194920
What this trial is testing

Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function

Who this might be right for
Thyroid GoiterThyroid CarcinomaMultinodular Goiter+1 more
University of Roma La Sapienza 20
Post-approval studies (Phase 4)Study completedNCT00037518
What this trial is testing

An Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Who this might be right for
HyperparathyroidismParathyroid Neoplasms
Amgen 46